Not Signed In - European Medicines Agency statement on the suspension of use of Bextra
Fri, 08 Apr 2005 07:00 PM EST
... Following discussions with the European Medicines Agency, Pfizer has agreed to the suspension of use of Bextra (valdecoxib) in Europe as an interim measure pending finalisation of the assessment of COX-2 inhibitors... click link for more info. ...
Related Topics
- Valdecoxib
- Aluminum and Magnesium Hydroxide Oral Suspension
- Amoxicillin Oral Suspension
- Dicloxacillin Suspension
- Carbetapentane, Phenylephrine, and Pyrilamine oral suspension
- Black Alder
- Drowsiness and other side effects of medicines
- Ciprofloxacin Suspension
- Cefpodoxime Suspension
- Cefdinir Suspension
- Cefprozil Suspension
- Cefuroxime Suspension
- Erythromycin Oral Suspension
- Carbetapentane and Chlorpheniramine oral suspension
- Megestrol Oral Suspension
- Carbamazepine Suspension
- Oseltamivir Oral Suspension
- Adoption
- Over-the-Counter Medicines
- Ibuprofen and Pseudoephedrine Suspension
email this page
print this page
bookmark this page
feedback on this page
